Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity lowers target price on Arrow Exploration

(Sharecast News) - Analysts at Canaccord Genuity lowered their target price on Colombia-focussed oil firm Arrow Exploration from 50.0p to 44.0p on Thursday but acknowledged that near-term drilling was likely to reboot production growth. Canaccord Genuity said Arrow's recent operations update highlighted, in its view, the limitations of normal vertical/near-vertical wells to deliver "significant growth" at the company's Tapir licence in Colombia.

The Canadian bank also stated that Arrow's step-up in production in H224 was driven by horizontal drilling at its CN field, and that it thinks its operational template will likely have the most impact across the licence from now.

"The stock has reacted sharply downwards following the recent update. We recognise the market's disappointment as production has declined over the past couple of months, but the company is only in the very early stages of its 2025 operational programme," said Canaccord.

"We believe the forward drilling plans should set the path upwards once again from early Q2, and with the momentum backed by a strong balance sheet ($23.0m cash and no debt at 1 February) we maintain our 'buy' rating."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Sabien Technology inks invoice facility with chairman's firm
(Sharecast News) - Sabien Technology Group announced on Monday that it would enter into an invoice factoring facility with Parris Group, the family office of its executive chairman Richard Parris, to provide additional working capital as it expanded sales of its M2G Cloud Connect service.
CleanTech reports 17pc increase in Laguna Verde resource estimate
(Sharecast News) - CleanTech Lithium reported a 17% increase in the mineral resource estimate for its Laguna Verde project in Chile on Monday, following the acquisition of additional licences, positioning the asset among the country's key lithium developments earmarked for accelerated private-sector advancement.
Abingdon Health secures $2m contract with US-based client
(Sharecast News) - Abingdon Health announced on Monday that it has secured a contract worth about $2m to develop and scale up a new multiplex lateral flow diagnostic test for a US-based client.
Metsera agrees $10bn takeover by Pfizer, shares slide
(Sharecast News) - US biotech firm Metsera tumbled on Monday after it agreed to be bought by Pfizer in a sweetened $10bn deal, with Denmark's Novo Nordisk refraining from making an increased offer.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.